Shineco is an American listed company specializing in the medical healthcare field. It was founded in 1997 and listed on the NASDAQ Capital Market (Nasdaq: SISI) in 2016. With its global headquarter in Delaware, the United States, and Asian headquarter in the central business district in Beijing, it has several holding subsidiaries, including Shineco Life Science Group Hong Kong Co., Limited, Shineco Life Science Research Co.,Ltd., and Changzhou Biowin Pharmaceutical Co., Ltd..
As a large multinational medical group, Shineco has a global strategic vision and business capabilities. By focusing on investment, it has formed various business segments, such as POCT, early screening and detection of tumors, in medical institutions, medical devices, medical health services, innovative medicine and other fields, covering China, Asia Pacific, Europe and other countries and regions.